Title:
ANTI-IL-4R ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/200787
Kind Code:
A1
Abstract:
Disclosed in the present application are an antibody or an antigen-binding portion thereof binding to human IL-4R, a polynucleotide encoding the antibody or antigen-binding portion thereof, a vector comprising the polynucleotide, a host cell comprising the polynucleotide or vector, a method for preparing and purifying the antibody, and the use of the antibody or antigen-binding portion thereof.
Inventors:
LIU ZHIGANG (CN)
LIU YULAN (CN)
HAO XIAOBO (CN)
JIANG LEI (CN)
GUO JINGJING (CN)
LIU YULAN (CN)
HAO XIAOBO (CN)
JIANG LEI (CN)
GUO JINGJING (CN)
Application Number:
PCT/CN2018/100263
Publication Date:
October 24, 2019
Filing Date:
August 13, 2018
Export Citation:
Assignee:
BEIJING WISDOMAB BIOTECHNOLOGY CO LTD (CN)
GENRIX SHANGHAI BIOPHARMACEUTICAL CO LTD (CN)
CHONGQING GENRIX BIOPHARMACEUTICAL CO LTD (CN)
GENRIX SHANGHAI BIOPHARMACEUTICAL CO LTD (CN)
CHONGQING GENRIX BIOPHARMACEUTICAL CO LTD (CN)
International Classes:
C07K16/28; A61K39/00; A61K39/395; A61P37/08
Foreign References:
| CN106267190A | 2017-01-04 | |||
| CN105377894A | 2016-03-02 | |||
| CN108373505A | 2018-08-07 |
Attorney, Agent or Firm:
INSIGHT INTELLECTUAL PROPERTY LIMITED (CN)
Download PDF: